Frank Dunphy

5.8k citations

65 papers · 3.6k indexed · 2 hit papers · h-index 25

Impact in

Otorhinolaryngology top 1%
- Head and Neck Cancer Studies
Oncology top 1%
- Lung Cancer Research Studies
- Colorectal Cancer Treatments and Studies
- Neutropenia and Cancer Infections
- Cancer Treatment and Pharmacology

Papers in

Otorhinolaryngology 16
- Head and Neck Cancer Studies 16
Oncology 36
- Lung Cancer Research Studies 11
- Cancer Treatment and Pharmacology 10
- Neutropenia and Cancer Infections 10

Co-authors: Mark G. Kris Jeffrey Crawford James Boyd Everett E. Vokes David R. Gandara Vincent A. Miller F. Gamza Daniel D. Karp
Journals: Journal of Clinical Oncology (12 papers)Cancer (7 papers)Journal of Thoracic Oncology (4 papers)Head & Neck (4 papers)Clinical Cancer Research (2 papers)
Partner nations: United States Belgium United Kingdom

In The Last Decade

Frank Dunphy

65 papers receiving 3.5k citations

Hit Papers

align trajectories log scale

Osimertinib for pretreated EGFR Thr790Met-positive advanced non-small-cell lung cancer (AURA2): a multicentre, open-label, single-arm, phase 2 study 2016 · 502 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2016 The Lancet Oncology
2000 Journal of Clinical Oncology

Peers

Countries citing papers authored by Frank Dunphy

Since Specialization

Citations

This map shows the geographic impact of Frank Dunphy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank Dunphy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank Dunphy more than expected).

Fields of papers citing papers by Frank Dunphy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank Dunphy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank Dunphy. The network helps show where Frank Dunphy may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Frank Dunphy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Frank Dunphy Line = papers co-authored together Frank Dunphy links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Immune Activation in Early-Stage Non–Small Cell Lung Cancer Patients Receiving Neoadjuvant Chemotherapy Plus Ipilimumab Clinical Cancer Research ·John S. Yi, Neal Ready, Patrick Healy, Чепанова Евгения Ивановна, Rawan Saber Al-khateeb, Mark F. Berry, P. Purroy, Jeffrey Clarke, Jeffrey Crawford, Betty C. Tong, David H. Harpole, Thomas A. D’Amico, Frances McSherry, Frank Dunphy, Shannon J. McCall, Jared D. Christensen, Xiaofei Wang, Kent J. Weinhold	2017	62
2	Toxicity of definitive and post-operative radiation following ipilimumab in non-small cell lung cancer Lung Cancer ·Matthew J. Boyer, Lin Gu, Xiaofei Wang, Chris R. Kelsey, David S. Yoo, Mark W. Onaitis, Frank Dunphy, Jeffrey Crawford, Neal Ready, Joseph K. Salama	2016	26
3	A randomized phase II study of the MEK1/MEK2 inhibitor trametinib (GSK1120212) compared with docetaxel in KRAS-mutant advanced non-small-cell lung cancer (NSCLC) Annals of Oncology ·George R. Blumenschein, Egbert F. Smit, David Planchard, Dongwook Kim, J. Cadranel, Tommaso De Pas, Frank Dunphy, Katalin Udud, Myung‐Ju Ahn, Nasser H. Hanna, Ji Hyun Kim, Julien Mazières, Sang Wan Kim, Paul Baas, Erica Rappold, Suman Redhu, von Segesser Georg, Frank Wu, Pasi A. Jänne	2015	248
4	Phase 1 Dose Escalation Study of Accelerated Radiation Therapy With Concurrent Chemotherapy for Locally Advanced Lung Cancer International Journal of Radiation OncologyBiologyPhysics ·Chris R. Kelsey, Shiva K. Das, Lin Gu, Frank Dunphy, Neal Ready, Lawrence B. Marks	2015	9
5	A Phase II Trial of Carboplatin/Vinorelbine with Pegfilgrastim Support for the Treatment of Patients with Advanced Non-small Cell Lung Cancer Journal of Thoracic Oncology ·Richard F. Riedel, Erik Skramstad, Jennifer Garst, Frank Dunphy, James E. Herndon, Susan Blackwell, Sally Barbour, Jeffrey Crawford	2007	9
6	Assessing the ability of the antiangiogenic and anticytokine agent thalidomide to modulate radiation-induced lung injury International Journal of Radiation OncologyBiologyPhysics ·Mitchell S. Anscher, Jennifer Garst, Lawrence B. Marks, Nicole Larrier, Frank Dunphy, James E. Herndon, Robert Clough, Rémi Vuillemin et Kjerstin Aukrust, Željko Vujašković, S. Zhou, Mark W. Dewhirst, Timothy D. Shafman, Jeffrey Crawford	2006	14
7	Intratumoral cisplatin/epinephrine gel in advanced head and neck cancer: A multicenter, randomized, double‐blind, phase III study in North America Head & Neck ·Dan J. Castro, Kasi S. Sridhar, Harinder S. Garewal, Glenn Mills, Barry L. Wenig, Frank Dunphy, Peter D. Costantino, Richard D. Leavitt, Morgan E. Stewart, Elaine K. Orenberg	2003	28
8	The Role of Intratumoral Therapy With Cisplatin/Epinephrine Injectable Gel in the Management of Advanced Squamous Cell Carcinoma of the Head and Neck Archives of Otolaryngology - Head and Neck Surgery ·Barry L. Wenig, Jochen A. Werner, Dan J. Castro, Kasi S. Sridhar, Harinder S. Garewal, W. Kehrl, A Płużańska, Mike Birmingham, Peter D. Costantino, Glenn Mills, Frank Dunphy, Elaine K. Orenberg, Richard D. Leavitt	2002	30
9	Induction paclitaxel and carboplatin for patients with head and neck carcinoma Cancer ·Frank Dunphy, Fu'ad Andrawus, Bruce R. Harrison, Kathryn Trinkaus, Han Jo Kim, Brendan C. Stack, Burton Needles, James Boyd	2001	33
10	Phase I dose escalation study of topotecan combined with alternating schedules of paclitaxel and carboplatin in advanced solid tumors Annals of Oncology ·Frank Dunphy, Theresa Dunleavy, Bruce R. Harrison, Ricardo Moreno-Cuesta, T Pylypenko, Steven M. Pincus, John M. Richart, Paul J. Petruska	2001	5
11	Initial evaluation of pulmonary abnormalities: CT-guided fine-needle aspiration biopsy and fluoride-18 fluorodeoxyglucose positron emission tomography correlation Diagnostic Cytopathology ·Brian T. Collins, Val J. Lowe, Frank Dunphy	2000	11
12	Primary and Recurrent Early Stage Laryngeal Cancer: Preliminary Results of 2-[Fluorine 18]fluoro-2-deoxy-d-glucose PET Imaging Radiology ·Val J. Lowe, Han Kim, James Boyd, Maria G Castro, Frank Dunphy, James Fletcher	1999	20
13	Correlation of CT-guided fine-needle aspiration biopsy of the liver with fluoride-18 fluorodeoxyglucose positron emission tomography in the assessment of metastatic hepatic abnormalities Diagnostic Cytopathology ·Brian T. Collins, Val J. Lowe, Frank Dunphy	1999	5
14	Erythropoietin reduces anemia and transfusions Cancer ·Frank Dunphy, Bruce R. Harrison, Fu'ad Andrawus, Masoud Ayoubi, GuangMing Sheng, James Boyd	1999	42
15	Randomized comparison of G-CSF + GM-CSF vs G-CSF alone for mobilization of peripheral blood stem cells: effects on hematopoietic recovery after high-dose chemotherapy Bone Marrow Transplantation ·Gary Spitzer, Douglas Adkins, 長子妹島, William S. Velasquez, C. Edward Bowers, Frank Dunphy, N Kronmueller, J Zawadzki, W McIntyre, Paul J. Petruska	1997	60
16	High- dose therapy with stem cell support in solid tumors Medical Oncology ·Gary Spitzer, Frank Dunphy, Oğuzhan Özkaya, Douglas R. Adkins	1994	1
17	Randomized study of growth factors post-peripheral-blood stem-cell transplant: neutrophil recovery is improved with modest clinical benefit. Journal of Clinical Oncology ·G Spitzer, Douglas R. Adkins, V. Spencer, Frank Dunphy, Paul J. Petruska, W S Velasquez, C. Edward Bowers, N Kronmueller, J Zawadzki, W McIntyre	1994	110
18	Factors predicting long-term survival for metastatic breast cancer patients treated with high-dose chemotherapy and bone marrow support Cancer ·Frank Dunphy, Gary Spitzer, Jane Fornoff, Jonathan C. Yau, S. Huan, Karel A. Dicke, Aman U. Buzdar, Gabriel N. Hortobágyi	1994	79
19	A phase II study of mitoxantrone, etoposide, and thiotepa with autologous marrow support for patients with relapsed breast cancer. Journal of Clinical Oncology ·Ralph O. Wallerstein, Gary Spitzer, Frank Dunphy, S. Huan, Gabriel N. Hortobágyi, J. Yau, Aman U. Buzdar, Frankie A. Holmes, Richard L. Theriault, Michael S. Ewer	1990	43
20	Treatment of estrogen receptor-negative or hormonally refractory breast cancer with double high-dose chemotherapy intensification and bone marrow support. Journal of Clinical Oncology ·Frank Dunphy, Gary Spitzer, Aman U. Buzdar, Gabriel N. Hortobágyi, Leonard Horwitz, Jonathan C. Yau, Jorge A. Spinolo, Sundar Jagannath, Frankie A. Holmes, Ralph O. Wallerstein	1990	146

About Frank Dunphy

Frank Dunphy is a scholar working on Otorhinolaryngology, Oncology, Hematology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 65 papers that have together received 3.6k indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (16 papers), Lung Cancer Research Studies (11 papers), Lung Cancer Treatments and Mutations (10 papers), Cancer Treatment and Pharmacology (10 papers), Neutropenia and Cancer Infections (10 papers), Salivary Gland Tumors Diagnosis and Treatment (8 papers), Hematopoietic Stem Cell Transplantation (7 papers) and Cancer therapeutics and mechanisms (6 papers). The work is most often cited by research in Otorhinolaryngology (380 citations), Oncology (2.4k citations), Pulmonary and Respiratory Medicine (2.1k citations), Hematology (391 citations) and Cancer Research (476 citations). Frank Dunphy has collaborated with scholars based in United States, Belgium and United Kingdom. Frequent co-authors include Mark G. Kris, Jeffrey Crawford, James Boyd, Everett E. Vokes, David R. Gandara, Vincent A. Miller, F. Gamza, Daniel D. Karp, Jin Soo Lee and Yong Kim. Their work appears in journals such as Journal of Clinical Oncology, Cancer, Journal of Thoracic Oncology, Head & Neck and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact